ZEO ScientifiX launches monthly regenerative medicine educational series for physicians

Zeo ScientifiX, Inc.

In-person events titled 'The Future of Biologic Medicine' focus on extracellular vesicles and autologous biologics.
First event held early September 2024; second on October 4; next forum scheduled November 8, 2024 in Davie, FL.
Events include expert-led discussions, lab tour at Nova Southeastern University, and regulatory overview.
Company completed Phase 1 trials for flagship product Zofin and is seeking Phase 2 trials for multiple indications.
Regenerative medicine market projected to reach ~$175B by 2032, 22.8% annual growth rate.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.